These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 33975868)
1. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea. Seo SI; Park CH; You SC; Kim JY; Lee KJ; Kim J; Kim Y; Yoo JJ; Seo WW; Lee HS; Shin WG Gut; 2021 Nov; 70(11):2066-2075. PubMed ID: 33975868 [TBL] [Abstract][Full Text] [Related]
2. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Cheung KS; Chan EW; Wong AYS; Chen L; Wong ICK; Leung WK Gut; 2018 Jan; 67(1):28-35. PubMed ID: 29089382 [TBL] [Abstract][Full Text] [Related]
3. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study. Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826 [TBL] [Abstract][Full Text] [Related]
4. Risk of gastric cancer among long-term proton pump inhibitor users: a population-based cohort study. Kim JW; Jung HK; Lee B; Shin CM; Gong EJ; Hong J; Youn YH; Lee KJ Eur J Clin Pharmacol; 2023 Dec; 79(12):1699-1708. PubMed ID: 37861752 [TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitor use and the risk of metachronous gastric cancer after H. pylori eradication in patients who underwent endoscopic resection for gastric neoplasms: A population-based cohort study. Gong EJ; Jung HK; Lee B; Hong J; Kim JW; Shin CM; Youn YH; Lee KJ Aliment Pharmacol Ther; 2023 Oct; 58(7):668-677. PubMed ID: 37589510 [TBL] [Abstract][Full Text] [Related]
6. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578 [TBL] [Abstract][Full Text] [Related]
7. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes. Nasser SC; Slim M; Nassif JG; Nasser SM World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469 [TBL] [Abstract][Full Text] [Related]
8. Association Between Vonoprazan and the Risk of Gastric Cancer After Helicobacter pylori Eradication. Arai J; Miyawaki A; Aoki T; Niikura R; Hayakawa Y; Fujiwara H; Ihara S; Fujishiro M; Kasuga M Clin Gastroenterol Hepatol; 2024 Jun; 22(6):1217-1225.e6. PubMed ID: 38354970 [TBL] [Abstract][Full Text] [Related]
9. Statins Were Associated with a Reduced Gastric Cancer Risk in Patients with Eradicated Cheung KS; Chan EW; Wong AYS; Chen L; Seto WK; Wong ICK; Leung WK Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):493-499. PubMed ID: 31792089 [TBL] [Abstract][Full Text] [Related]
10. Dose-dependent association of proton pump inhibitors use with gastric intestinal metaplasia among Helicobacter pylori-positive patients. Snir Y; Leibovitzh H; Leibovici-Weissman Y; Vilkin A; Cohen AD; Shochat T; Niv Y; Dotan I; Feldhamer I; Boltin D; Levi Z United European Gastroenterol J; 2021 Apr; 9(3):343-353. PubMed ID: 32962566 [TBL] [Abstract][Full Text] [Related]
11. Characteristic analysis of early gastric cancer after Liu X; Wang X; Mao T; Yin X; Wei Z; Fu J; Wu J; Li X Ann Med; 2023 Dec; 55(1):2231852. PubMed ID: 37450336 [TBL] [Abstract][Full Text] [Related]
12. Effect of Helicobacter pylori eradication and high-density lipoprotein on the risk of de novo gastric cancer development. Nam SY; Park BJ; Nam JH; Kook MC Gastrointest Endosc; 2019 Sep; 90(3):448-456.e1. PubMed ID: 31034810 [TBL] [Abstract][Full Text] [Related]
13. Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors. Schneider JL; Kolitsopoulos F; Corley DA Aliment Pharmacol Ther; 2016 Jan; 43(1):73-82. PubMed ID: 26541643 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection. Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N World J Gastroenterol; 2015 Apr; 21(16):4954-60. PubMed ID: 25945009 [TBL] [Abstract][Full Text] [Related]
15. Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals. Leung WK; Wong IOL; Cheung KS; Yeung KF; Chan EW; Wong AYS; Chen L; Wong ICK; Graham DY Gastroenterology; 2018 Jul; 155(1):67-75. PubMed ID: 29550592 [TBL] [Abstract][Full Text] [Related]
16. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden. Brusselaers N; Wahlin K; Engstrand L; Lagergren J BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798 [TBL] [Abstract][Full Text] [Related]
17. Family History of Gastric Cancer and Choi IJ; Kim CG; Lee JY; Kim YI; Kook MC; Park B; Joo J N Engl J Med; 2020 Jan; 382(5):427-436. PubMed ID: 31995688 [TBL] [Abstract][Full Text] [Related]